FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this is a report of a second or subsequent transplant, check here.

  Continue with question 177.  

 
 
1  What was the date of diagnosis of Fanconi Anemia? __ __ __ __ - __ __- __ __  

 
 

2  Was the diagnosis made in utero?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify test(s) performed to identify disease: 
 

3  Amniocentesis

    
 nmlkji

yes  
 nmlkji

no  

 
 

4  Chorionic villous sampling (CVS)

    
 nmlkji

yes  
 nmlkji

no  

 
 

5  Fibroblasts

    
 nmlkji

yes  
 nmlkji

no  

 
 

6  Other test

    
 nmlkji

yes  
 nmlkji

no  

 
 
7  Specify other test:    

 
 

8  Was the recipient diagnosed with any congenital abnormalities?

    
 nmlkji

yes  
 nmlkji

no  

 
 

9  Abnormal facies (snub nose, thick upper lip, epicanthic folds, hypertelorism)

    
 nmlkji

yes  
 nmlkji

no  

 
 

10  Ear abnormalities

    
 nmlkji

yes  
 nmlkji

no  

  Key Fields 

Disease Assessment at Diagnosis Questions: 1 - 141

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 12



 
 

11  Eye abnormalities (strabismus, cataract, microphthalmia)

    
 nmlkji

yes  
 nmlkji

no  

 
 

12  Other neurologic abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 
13  Specify:    

 
 

14  Microcephaly

    
 nmlkji

yes  
 nmlkji

no  

 
 

15  Palate or jaw abnormalities (cleft palate and/or lip, Pierre Robin syndrome, small jaw or mouth)

    
 nmlkji

yes  
 nmlkji

no  

 
 

16  Abnormal neck (short or webbed neck)

    
 nmlkji

yes  
 nmlkji

no  

 
 

17  Cardiac abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 

18  Exocrine pancreatic deficiency

    
 nmlkji

yes  
 nmlkji

no  

 
 

19  Gastrointestinal abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 

20  Genital abnormalities (cryptorchism, hypoplasia)

    
 nmlkji

yes  
 nmlkji

no  

 
 

21  Kidney or urinary tract abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 

22  Thumb abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 

23  Radius abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 

24  Other skeletal abnormalities (syndactyly, chinodactyl, abnormal ribs, metaphyseal dyschondroplasia)

    
 nmlkji

yes  
 nmlkji

no  

 
 

25  Cafe au lait spots

    
 nmlkji

yes  
 nmlkji

no  

 
 

26  Other skin abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 
27  Specify:    

 
 

28  Other congenital abnormalities

    
 nmlkji

yes  
 nmlkji

no  

 
 
29  Specify:    

 
 
30  Specify the date that abnormal blood results were first observed __ __ __ __ - __ __- __ __  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 12



 
 

31  Specify the presenting hematologic disorder

    
 nmlkji

acute leukemia  -Complete a corresponding Leukemia insert 

 nmlkji
cytopenia  

 nmlkji
myelodysplasia  -Complete a Form 2014-MDS insert 

 nmlkji
other disorder  

 

Specify cytopenia: 
 

32  Anemia (Hb <10 g/dL)

    
 nmlkji

yes  
 nmlkji

no  

 
 

33  Thrombocytopenia (platelets < 100,000/mm3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

34  Neutropenia (ANC <1,000/mm)3

    
 nmlkji

yes  
 nmlkji

no  

 
 
35  Specify other hematologic disorder    

 
 

36  Was the bone marrow examined at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
37  Specify date of bone marrow examination __ __ __ __ - __ __- __ __  

 
 

38  Specify cellularity

    
 nmlkji

Decreased  
 nmlkji

Normal  
 nmlkji

Increased  
 nmlkji

Unknown  

 
 

39  Were dysplastic features present at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
40  Blasts in marrow    %  

 
 

41  Was bone marrow karyotyping present at diagnosis?

    
 nmlkji

Yes  

 nmlkji
yes, but no 

evaluable 
metaphases  

 nmlkji
No  

 nmlkji
Unknown  

 
 

42  Was karyotype normal?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify abnormalities identified: 
 

43  +4

    
 nmlkji

yes  
 nmlkji

no  

 
 

44  +5

    
 nmlkji

yes  
 nmlkji

no  

 
 

45  -7

    
 nmlkji

yes  
 nmlkji

no  

 
 

46  +8

    
 nmlkji

yes  
 nmlkji

no  

  Cytogenetic Studies/Sensitivity to DNA Cross-Linking Agents (1) Questions: 41 - 141 

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 12



 
 

47  +11

    
 nmlkji

yes  
 nmlkji

no  

 
 

48  +13

    
 nmlkji

yes  
 nmlkji

no  

 
 

49  +14

    
 nmlkji

yes  
 nmlkji

no  

 
 

50  -17

    
 nmlkji

yes  
 nmlkji

no  

 
 

51  -18

    
 nmlkji

yes  
 nmlkji

no  

 
 

52  -20

    
 nmlkji

yes  
 nmlkji

no  

 
 

53  +21

    
 nmlkji

yes  
 nmlkji

no  

 
 

54  +22

    
 nmlkji

yes  
 nmlkji

no  

 
 

55  -X

    
 nmlkji

yes  
 nmlkji

no  

 
 

56  -Y

    
 nmlkji

yes  
 nmlkji

no  

 
 

57  del(5q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

58  del(7q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

59  del(9q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

60  del(11q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

61  del(20q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

62  inv(3) or t(3;3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

63  inv(16) or t(16;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

64  t(1;7)

    
 nmlkji

yes  
 nmlkji

no  

 
 

65  t(5;7)

    
 nmlkji

yes  
 nmlkji

no  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 12



 
 

66  t(6;9)

    
 nmlkji

yes  
 nmlkji

no  

 
 

67  t(8;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

68  t(8;21)

    
 nmlkji

yes  
 nmlkji

no  

 
 

69  t(15;17) and variants

    
 nmlkji

yes  
 nmlkji

no  

 
 

70  balanced abn(11q23)

    
 nmlkji

yes  
 nmlkji

no  

 
 

71  abn(12p)

    
 nmlkji

yes  
 nmlkji

no  

 
 

72  loss of 17p

    
 nmlkji

yes  
 nmlkji

no  

 
 

73  complex (>=3 distinct abnormalities)

    
 nmlkji

yes  
 nmlkji

no  

 
 

74  increased breaks

    
 nmlkji

yes  
 nmlkji

no  

 
 

75  other karyotype abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 
76  Specify other abnormality    

 
 
77  Date of karyotyping __ __ __ __ - __ __- __ __  

 
 

78  Is a copy of the cytogenetic report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

79  Was complementation group testing performed at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify groups identified: 
 

80  FANCA

    
 nmlkji

yes  
 nmlkji

no  

 
 

81  FANCB

    
 nmlkji

yes  
 nmlkji

no  

 
 

82  FANCC

    
 nmlkji

yes  
 nmlkji

no  

 
 

83  FANCD2

    
 nmlkji

yes  
 nmlkji

no  

 
 

84  FANCE

    
 nmlkji

yes  
 nmlkji

no  

 
 

85  FANCF

    
 nmlkji

yes  
 nmlkji

no  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 12



 
 

86  FANCG

    
 nmlkji

yes  
 nmlkji

no  

 
 

87  Other group

    
 nmlkji

yes  
 nmlkji

no  

 
 
88  Specify:    

 
 

89  Is a copy of the complementation group report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

90  Were any genetic mutations identified?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify mutation origin: 
 

91  Maternal

    
 nmlkji

yes  
 nmlkji

no  

 
 

92  Paternal

    
 nmlkji

yes  
 nmlkji

no  

 
 

93  Was a mutation analysis of cloned Fanconi Anemia genes performed at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
94  Specify the date the analysis was performed __ __ __ __ - __ __- __ __  

 

Specify mutation(s) and specify value: 
 

95  Exon

    
 nmlkji

yes  
 nmlkji

no  

 
 
96  Specify    

 
 

97  Intron

    
 nmlkji

yes  
 nmlkji

no  

 
 
98  Specify    

 
 

99  Nucleotide change (e.g, 732G>C)

    
 nmlkji

yes  
 nmlkji

no  

 
 
100  Specify    

 
 

101  Amino acid changes(e.g., L244F)

    
 nmlkji

yes  
 nmlkji

no  

 
 
102  Specify    

 
 

103  Specify the mutation type

    
 nmlkji

substitution  
 nmlkji

deletion  
 nmlkji

insertion  

 
 

104  Is a copy of the mutation analysis report attached?

    
 nmlkji

yes  
 nmlkji

no  

 

Maternity Mutation Analysis: 
 

105  Was a mutation analysis of cloned Fanconi Anemia genes performed at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
106  Specify the date the analysis was performed: __ __ __ __ - __ __- __ __  

 

Specify mutation(s) and specify value: 
 

107  Exon

    
 nmlkji

yes  
 nmlkji

no  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 6 / 12



 
 
108  Specify:    

 
 

109  Intron:

    
 nmlkji

yes  
 nmlkji

no  

 
 
110  Specify:    

 
 

111  Nucleotide change (e.g., 732G>C)

    
 nmlkji

yes  
 nmlkji

no  

 
 
112  Specify:    

 
 

113  Amino acid changes (e.g., L244F)

    
 nmlkji

yes  
 nmlkji

no  

 
 
114  Specify:    

 
 

115  Specify mutation type:

    
 nmlkji

substitution  
 nmlkji

deletion  
 nmlkji

insertion  

 
 

116  Is a copy of the mutation analysis report attached?

    
 nmlkji

yes  
 nmlkji

no  

 

Paternity Mutation Analysis: 
 

117  Was a mutation analysis of cloned Fanconi Anemia genes performed at any time prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
118  Specify the date the analysis was performed __ __ __ __ - __ __- __ __  

 
 

119  Exon

    
 nmlkji

yes  
 nmlkji

no  

 
 
120  Specify    

 
 

121  Intron

    
 nmlkji

yes  
 nmlkji

no  

 
 
122  Specify    

 
 

123  Nucleotide change
(e.g, 732G>C) 

    
 nmlkji

yes  
 nmlkji

no  

 
 
124  Specify    

 
 

125  Amino acid changes
(e.g., L244F) 

    
 nmlkji

yes  
 nmlkji

no  

 
 
126  Specify    

 
 

127  Specify the mutation type

    
 nmlkji

substitution  
 nmlkji

deletion  
 nmlkji

insertion  

 
 

128  Is a copy of the mutation analysis report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

129  Were the recipient's bone marrow cells or peripheral blood mononuclear cells tested for sensitivity to cross-linking agents?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
130  Specify the date the testing was performed __ __ __ __ - __ __- __ __  

 
 

131  Specify the type of cross-linking agent used

    
 nmlkji

diepoxybutane  
 nmlkji

mitomycin C  
 nmlkji

other agent  

 
 
132  Specify other agent    

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 7 / 12



 
 

133  Were chromatid aberrations present on an unstressed preparation?

    
 nmlkji

Yes  
 nmlkji

No  
 nmlkji

Not evaluable  

 
 
134  Total number of cells studied    

 
 
135  Number of aberrations per cell    

 
 
136  Number of cells with no aberrations    

 
 

137  Were chromatid aberrations present on a stressed preparation?

    
 nmlkji

Yes  
 nmlkji

No  
 nmlkji

Not evaluable  

 
 
138  Total number of cells studied    

 
 
139  Number of aberrations per cell    

 
 
140  Number of cells with no aberrations    

 
 

141  Is a copy of the report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

142  Were any other genetically related family members affected?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify family member(s): 
 

143  Sibling

    
 nmlkji

yes  
 nmlkji

no  

 
 

144  Cousin

    
 nmlkji

yes  
 nmlkji

no  

 
 

145  Parent

    
 nmlkji

yes  
 nmlkji

no  

 
 

146  Aunt / uncle

    
 nmlkji

yes  
 nmlkji

no  

 
 

147  Other relative

    
 nmlkji

yes  
 nmlkji

no  

 
 
148  Specify relationship    

 
 

149  Is the recipient genetically related to his/her parents?

    
 nmlkji

yes, both mother and father  

 nmlkji
yes, mother only  

 nmlkji
yes, father only  

 nmlkji
no, not genetically related to mother or father  

 nmlkji
Unknown  

 
 

150  (Related donors only) Were the donor's blood or bone marrow cells tested for sensitivity to cross-linking agents?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
151  Specify the date testing was performed __ __ __ __ - __ __- __ __  

 
 

152  Specify the type of cross-linking agent used

    
 nmlkji

diepoxybutane  
 nmlkji

mitomycin C  
 nmlkji

other agent  

 
 
153  Specify other agent    

  Familial History of Disease Questions: 142 - 176

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 8 / 12



 
 

154  Were chromatid aberrations present on an unstressed preparation?

    
 nmlkji

Yes  
 nmlkji

No  
 nmlkji

Not evaluable  

 
 
155  Total number of cells studied    

 
 
156  Number of aberrations per cell    

 
 
157  Number of cells with no aberrations    

 
 

158  Were chromatid aberrations present on a stressed preparation?

    
 nmlkji

Yes  
 nmlkji

No  
 nmlkji

Not evaluable  

 
 
159  Total number of cells studied    

 
 
160  Number of aberrations per cell    

 
 
161  Number of cells with no aberrations    

 
 

162  Is a copy of the report attached?

    
 nmlkji

yes  
 nmlkji

no  

 
 

163  Was the recipient treated with androgens prior to HSCT?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

164  Was the recipient treated with corticosteroids prior to HSCT?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

165  Did the recipient receive growth factors prior to HSCT?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

If yes, specify cytokine(s) given: 
 

166  Erythropoietin (includes all forms of erythropoietin/darbepoetin)

    
 nmlkji

yes  
 nmlkji

no  

 
 

167  G-CSF

    
 nmlkji

yes  
 nmlkji

no  

 
 

168  GM-CSF

    
 nmlkji

yes  
 nmlkji

no  

 
 

169  IL3

    
 nmlkji

yes  
 nmlkji

no  

 
 

170  Neulasta

    
 nmlkji

yes  
 nmlkji

no  

 
 

171  Stem cell factor

    
 nmlkji

yes  
 nmlkji

no  

 
 

172  Other growth factor

    
 nmlkji

yes  
 nmlkji

no  

 
 
173  Specify other agent    

 
 

174  Did the recipient receive red blood cell transfusions between diagnosis and the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

 
 

175  Specify the total number of donor exposures (best estimate)

    
 nmlkji

1-5  
 nmlkji

6-10  
 nmlkji

11-20  
 nmlkji

21-30  
 nmlkji

31-40  
 nmlkji

41-50  
 nmlkji

>=51  
 nmlkji

Unknown  

 
 

176  Did the recipient receive platelet transfusions in the four weeks prior to the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 9 / 12



 
 

177  What was the recipient's disease status immediately prior to the preparative regimen?

    
 nmlkji

stable cytopenia, co cytogenetic abnormalities (no MDS)  

 nmlkji
stable cytopenia with cytogenetic abnormalities (no MDS)  

 nmlkji
progressive cytopenia  

 nmlkji
myelodysplasia  -Complete a Form 2014-MDS insert 

 nmlkji
leukemia, untreated  -Complete a corresponding Leukemia insert 

 nmlkji
leukemia, treated  -Complete a corresponding Leukemia insert 

 
 

178  Was the recipient's bone marrow examined at any time between diagnosis and the preparative regimen?

    
 nmlkji

Yes  

 nmlkji
yes, but no 

evaluable 
metaphases  

 nmlkji
No  

 nmlkji
Unknown  

 
 

179  Were any karyotype abnormalities identified?

    
 nmlkji

yes  
 nmlkji

no  

 

Specify abnormalities identified: 
 

180  +4

    
 nmlkji

yes  
 nmlkji

no  

 
 

181  +5

    
 nmlkji

yes  
 nmlkji

no  

 
 

182  -7

    
 nmlkji

yes  
 nmlkji

no  

 
 

183  +8

    
 nmlkji

yes  
 nmlkji

no  

 
 

184  +11

    
 nmlkji

yes  
 nmlkji

no  

 
 

185  +13

    
 nmlkji

yes  
 nmlkji

no  

 
 

186  +14

    
 nmlkji

yes  
 nmlkji

no  

 
 

187  -17

    
 nmlkji

yes  
 nmlkji

no  

 
 

188  -18

    
 nmlkji

yes  
 nmlkji

no  

 
 

189  -20

    
 nmlkji

yes  
 nmlkji

no  

  Clinical Features Just Prior to the Preparative Regimen Questions: 177 - 177

  Hematologic Parameters Immediately Prior to the Preparative Regimen Questions: 178 - 215

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 10 / 12



 
 

190  +21

    
 nmlkji

yes  
 nmlkji

no  

 
 

191  +22

    
 nmlkji

yes  
 nmlkji

no  

 
 

192  -X

    
 nmlkji

yes  
 nmlkji

no  

 
 

193  -Y

    
 nmlkji

yes  
 nmlkji

no  

 
 

194  del(5q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

195  del(7q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

196  del(9q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

197  del(11q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

198  del(20q)

    
 nmlkji

yes  
 nmlkji

no  

 
 

199  inv(3) or t(3;3)

    
 nmlkji

yes  
 nmlkji

no  

 
 

200  inv(16) or t(16;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

201  t(1;7)

    
 nmlkji

yes  
 nmlkji

no  

 
 

202  t(5;7)

    
 nmlkji

yes  
 nmlkji

no  

 
 

203  t(6;9)

    
 nmlkji

yes  
 nmlkji

no  

 
 

204  t(8;16)

    
 nmlkji

yes  
 nmlkji

no  

 
 

205  t(8;21)

    
 nmlkji

yes  
 nmlkji

no  

 
 

206  t(15;17) and variants

    
 nmlkji

yes  
 nmlkji

no  

 
 

207  balanced abn(11q23)

    
 nmlkji

yes  
 nmlkji

no  

 
 

208  abn(12p)

    
 nmlkji

yes  
 nmlkji

no  

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 11 / 12



 
 

209  loss of 17p

    
 nmlkji

yes  
 nmlkji

no  

 
 

210  complex (>=3 distinct abnormalities)

    
 nmlkji

yes  
 nmlkji

no  

 
 

211  increased breaks

    
 nmlkji

yes  
 nmlkji

no  

 
 

212  other karyotype abnormality

    
 nmlkji

yes  
 nmlkji

no  

 
 
213  Specify other abnormality    

 
 
214  Date of karyotyping __ __ __ __ - __ __- __ __  

 
 

215  Is a copy of the cytogenetic report attached?

    
 nmlkji

yes  
 nmlkji

no  

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

Form 2029 R2.0: Fanconi Anemia/Constitutional Anemia Pre-HSCT Data  
Center:  CRID: 

                CIBMTR Form 2029 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 12 / 12